CACNA2D4 and neoplasm: Five genes, CACNB4 (FCMSS 0.65), MAP3K6 (FCMSS 0.66), CD14 (FCMSS 0.66), CACNA2D4 (FCMSS 0.66), and MAP4K4 (FCMSS 1.52) had slightly stronger FC for MSS-specific tumors than for all tumor combined (FCoverall 0.67, 0.73, 0.68, 0.67, and 1.47, respectively).